Oxidative stress in chronic kidney disease

K Daenen, A Andries, D Mekahli, A Van Schepdael… - Pediatric …, 2019 - Springer
Oxidative stress (OS), defined as disturbances in the pro-/antioxidant balance, is harmful to
cells due to the excessive generation of highly reactive oxygen (ROS) and nitrogen (RNS) …

Oxidative stress in hemodialysis patients: a review of the literature

V Liakopoulos, S Roumeliotis, X Gorny… - Oxidative medicine …, 2017 - Wiley Online Library
Hemodialysis (HD) patients are at high risk for all‐cause mortality and cardiovascular
events. In addition to traditional risk factors, excessive oxidative stress (OS) and chronic …

Myeloperoxidase: friend and foe

SJ Klebanoff - Journal of leukocyte biology, 2005 - academic.oup.com
Neutrophilic polymorphonuclear leukocytes (neutrophils) are highly specialized for their
primary function, the phagocytosis and destruction of microorganisms. When coated with …

Chronic kidney disease: effects on the cardiovascular system

EL Schiffrin, ML Lipman, JFE Mann - Circulation, 2007 - Am Heart Assoc
Accelerated cardiovascular disease is a frequent complication of renal disease. Chronic
kidney disease promotes hypertension and dyslipidemia, which in turn can contribute to the …

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences

K Kalantar-Zadeh, TA Ikizler, G Block, MM Avram… - American journal of …, 2003 - Elsevier
Protein-energy malnutrition (PEM) and inflammation are common and usually concurrent in
maintenance dialysis patients. Many factors that appear to lead to these 2 conditions …

Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome

F Locatelli, B Canaud, KU Eckardt… - Nephrology Dialysis …, 2003 - academic.oup.com
Introduction. Patients affected by end‐stage renal disease (ESRD) experience an excess of
morbidity and mortality due to cardiovascular disease (CVD), which cannot be fully …

Myeloperoxidase and cardiovascular disease

SJ Nicholls, SL Hazen - Arteriosclerosis, thrombosis, and vascular …, 2005 - Am Heart Assoc
Myeloperoxidase (MPO) is a leukocyte-derived enzyme that catalyzes the formation of a
number of reactive oxidant species. In addition to being an integral component of the innate …

Apolipoprotein AI is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

L Zheng, B Nukuna, ML Brennan… - The Journal of …, 2004 - Am Soc Clin Investig
In recent studies we demonstrated that systemic levels of protein-bound nitrotyrosine
(NO2Tyr) and myeloperoxidase (MPO), a protein that catalyzes generation of nitrating …

Myeloperoxidase and its contributory role in inflammatory vascular disease

D Lau, S Baldus - Pharmacology & therapeutics, 2006 - Elsevier
Myeloperoxidase (MPO), a heme protein abundantly expressed in polymorphonuclear
neutrophils (PMN), has long been viewed to function primarily as a bactericidal enzyme …

Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?

A Otocka-Kmiecik, DP Mikhailidis, SJ Nicholls… - Progress in lipid …, 2012 - Elsevier
High density lipoprotein (HDL) has many properties, which contribute to its atheroprotective
role. However, some recent clinical trials have identified subjects with the progression of …